CB
GSK icon

Cadence Bank’s GSK GSK Stock Holding History

Cadence Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$882K Buy
17,982
+352
+2% +$16.4K 0.05% 180
2025
Q3 		$761K Buy
17,630
+146
+0.8% +$5.7K 0.05% 195
2025
Q2 		$671K Buy
17,484
+504
+3% +$19.3K 0.04% 204
2025
Q1 		$658K Buy
16,980
+1
+0% +$37 0.05% 198
2024
Q4 		$574K Sell
16,979
-10
-0.1% -$360 0.04% 209
2024
Q3 		$695K Sell
16,989
-1,491
-8% -$61K 0.05% 194
2024
Q2 		$711K Buy
18,480
+570
+3% +$24K 0.05% 165
2024
Q1 		$768K Buy
17,910
+1,573
+10% +$64.9K 0.06% 186
2023
Q4 		$605K Buy
16,337
+1,655
+11% +$59.4K 0.05% 203
2023
Q3 		$532K Buy
14,682
+519
+4% +$18.4K 0.05% 207
2023
Q2 		$505K Buy
14,163
+5,174
+58% +$186K 0.04% 218
2023
Q1 		$320K Buy
8,989
+60
+0.7% +$2.1K 0.03% 263
2022
Q4 		$314K Buy
8,929
+634
+8% +$21.1K 0.03% 274
2022
Q3 		$244K Buy
+8,295
New +$314K 0.03% 295
2020
Q1 		– Sell
-4,510
Closed -$265K – 191
2019
Q4 		$265K Buy
4,510
+91
+2% +$5.06K 0.05% 174
2019
Q3 		$236K Buy
+4,419
New +$227K 0.02% 201
2019
Q2 		– Sell
-4,466
Closed -$233K – 227
2019
Q1 		$233K Sell
4,466
-1,310
-23% -$65.5K 0.02% 215
2018
Q4 		$276K Sell
5,776
-808
-12% -$39.8K 0.03% 191
2018
Q3 		$331K Sell
6,584
-694
-10% -$35.3K 0.03% 196
2018
Q2 		$367K Buy
7,278
+772
+12% +$38.9K 0.03% 179
2018
Q1 		$318K Sell
6,506
-800
-11% -$37.3K 0.03% 189
2017
Q4 		$324K Buy
+7,306
New +$338K 0.03% 190

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cadence Bank's GSK Position: Q4 2025 in Review

Cadence Bank increased its GSK (GSK) stake by 2% in Q4 2025, buying an estimated $16.4K and bringing the position to 17,982 shares worth $882K. The position accounts for 0.05% of the portfolio, ranked #180.

Cadence Bank first reported a position in GSK in Q4 2017 and has held it in 22 quarters since. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Cadence Bank held 17,982 shares of GSK worth $882K as of Q4 2025.
  • Cadence Bank bought 352 GSK shares in Q4 2025, an estimated $16.4K.
  • GSK made up 0.05% of Cadence Bank's portfolio in Q4 2025, its #180 holding.
  • Cadence Bank first reported a position in GSK in Q4 2017 and has held it in 22 quarters since.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.